UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Immunotherapy for skin cancer

International immunology, 2019-07, Vol.31 (7), p.465-475

2019

Volltextzugriff (PDF)

Merkel Cell Polyomavirus Large T Antigen Has Growth-Promoting and Inhibitory Activities

Journal of Virology, 2013-06, Vol.87 (11), p.6118-6126

2013

Volltextzugriff (PDF)

Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival

Clinical cancer research, 2018-02, Vol.24 (4), p.963-971

2018

Volltextzugriff (PDF)

Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma

Cancer immunology research, 2014-11, Vol.2 (11), p.1071-1079

2014

Volltextzugriff (PDF)

Incidence, demographics, and survival of malignant hemangioendothelioma in the United States

Cancer medicine (Malden, MA), 2023-07, Vol.12 (14), p.15101-15106

2023

Volltextzugriff (PDF)

Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e001591

2020

Volltextzugriff (PDF)

Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management

JAAD Case Reports, 2021-10, Vol.16, p.58-61

2021

Volltextzugriff (PDF)

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients

JAAD Case Reports, 2021-02, Vol.8, p.28-33

2021

Volltextzugriff (PDF)

Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma

Journal of investigative dermatology, 2021-08, Vol.141 (8), p.1897-1905

2021

Volltextzugriff (PDF)

Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade

Clinical cancer research, 2024-03, Vol.30 (6), p.1189

2024

Volltextzugriff (PDF)

Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma

Scientific reports, 2016-02, Vol.6 (1), p.21678-21678, Article 21678

2016

Volltextzugriff (PDF)

An In Vivo Model of Human Macrophages in Metastatic Melanoma

The Journal of immunology (1950), 2022-08, Vol.209 (3), p.606-620

2022

Volltextzugriff (PDF)

A second chance for success with BRAF and MEK inhibitors in melanoma

The lancet oncology, 2017-04, Vol.18 (4), p.418-419

2017

Volltextzugriff (PDF)

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency

Science translational medicine, 2022-02, Vol.14 (631), p.eabg8070

2022

Volltextzugriff (PDF)

Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia

The American journal of medicine, 2019-01, Vol.132 (1), p.e13-e14

2019

Volltextzugriff (PDF)

Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I

Cancer immunology research, 2014-01, Vol.2 (1), p.27-36

2014

Volltextzugriff (PDF)

Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas

Journal of clinical virology, 2011-11, Vol.52 (3), p.272-275

2011

Volltextzugriff (PDF)

Human CD4 + T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain

Cancer immunology research, 2019-10, Vol.7 (10), p.1727-1739

2019

Volltextzugriff (PDF)

Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I

Cancer immunology research, 2014, Vol.2 (1), p.27-36

2014

Volltextzugriff (PDF)

Correction: Diagnostic Biopsy Does Not Commonly Induce Intratumoral CD8 T Cell Infiltration in Merkel Cell Carcinoma

PloS one, 2012-10, Vol.7 (10)

2012

Volltextzugriff (PDF)

CD8+ Lymphocyte Intratumoral Infiltration as a Stage-Independent Predictor of Merkel Cell Carcinoma Survival

American journal of clinical pathology, 2014-10, Vol.142 (4), p.452-458

2014

Volltextzugriff (PDF)

Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls

Journal of clinical virology, 2009-02, Vol.44 (2), p.164-166

2009

Volltextzugriff (PDF)

Abstract I11: Targeting pancreatic cancer with TCR-engineered T cells

Cancer research (Chicago, Ill.), 2019-12, Vol.79 (24_Supplement), p.I11-I11

2019

Volltextzugriff (PDF)

Merkel Cell Carcinoma: Current United States Incidence and Projected Increases based on Changing Demographics

Journal of the American Academy of Dermatology, 2017-11, Vol.78 (3), p.457-463.e2

2017

Volltextzugriff (PDF)

Abstract 2980: Single cell RNA sequencing reveals AML immunoediting under pressure from engineered T cell therapy

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2980-2980

2018

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(50)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(23)
Humans
(17)
Oncology
(10)
Animals
(8)
Tumors
(8)
Biological And Medical Sciences
(6)
Carcinoma, Merkel Cell - Immunology
(6)
Immunology
(6)
Medical Sciences
(6)
Mice
(6)
Skin Neoplasms - Immunology
(6)
Carcinoma, Merkel Cell - Virology
(5)
Immunotherapy
(5)
Infectious Diseases
(5)
Carcinoma, Merkel Cell - Genetics
(4)
Carcinoma, Merkel Cell - Pathology
(4)
Cell Line, Tumor
(4)
Dermatology
(4)
Merkel Cell Polyomavirus - Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunotherapy for skin cancer

Merkel Cell Polyomavirus Large T Antigen Has Growth-Promoting and Inhibitory Activities

Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival

Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma

Incidence, demographics, and survival of malignant hemangioendothelioma in the United States

Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab

Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients

Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma

Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade

Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma

An In Vivo Model of Human Macrophages in Metastatic Melanoma

A second chance for success with BRAF and MEK inhibitors in melanoma

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency

Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia

Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I

Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas

Human CD4 + T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain

Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I

Correction: Diagnostic Biopsy Does Not Commonly Induce Intratumoral CD8 T Cell Infiltration in Merkel Cell Carcinoma

CD8+ Lymphocyte Intratumoral Infiltration as a Stage-Independent Predictor of Merkel Cell Carcinoma Survival

Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls

Abstract I11: Targeting pancreatic cancer with TCR-engineered T cells

Merkel Cell Carcinoma: Current United States Incidence and Projected Increases based on Changing Demographics

Abstract 2980: Single cell RNA sequencing reveals AML immunoediting under pressure from engineered T cell therapy

Aktive Filter

Suchergebnisse filtern